SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001193125-16-779953
Filing Date
2016-11-30
Accepted
2016-11-29 21:49:05
Documents
10

Document Format Files

Seq Description Document Type Size
1 S-1/A d271779ds1a.htm S-1/A 1037360
2 EX-1.1 d271779dex11.htm EX-1.1 176005
3 EX-3.11 d271779dex311.htm EX-3.11 84067
4 EX-4.3 d271779dex43.htm EX-4.3 92478
5 EX-5.1 d271779dex51.htm EX-5.1 11798
6 EX-23.1 d271779dex231.htm EX-23.1 1996
7 GRAPHIC g271779g27z79.jpg GRAPHIC 31712
8 GRAPHIC g271779g37s23.jpg GRAPHIC 148017
9 GRAPHIC g271779g38v62.jpg GRAPHIC 49875
10 GRAPHIC g271779g60c81.jpg GRAPHIC 2864
  Complete submission text file 0001193125-16-779953.txt   1725382
Mailing Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752
Business Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752 (508) 767-3861
RXi Pharmaceuticals Corp (Filer) CIK: 0001533040 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1/A | Act: 33 | File No.: 333-214199 | Film No.: 162023923
SIC: 2834 Pharmaceutical Preparations